Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Am J Hematol ; 55(2): 77-82, 1997 Jun.
Article in English | MEDLINE | ID: mdl-9209002

ABSTRACT

Starting from the observation that a number of consecutive patients with non-Hodgkin's lymphoma (NHL) resulted positive for hepatitis C virus (HCV) antibodies on routine testing, we set up a survey for HCV contact prevalence in all patients with lymphoproliferative disorders (LPD) followed in our institution. We searched for HCV antibodies by a third-generation ELISA technique, followed by a confirmation test (RIBA III); serum viral RNA and HCV genotype were investigated by a RT-PCR technique. We screened a total of 315 patients suffering from B-NHL (91), multiple myeloma (56), MGUS (48), chronic lymphocytic leukemia (57), Waldentrom's macroglobulinemia (13), Hodgkin's disease (HD)(43), and T-NHL (9). While only 1 of 52 patients with a non-B-LPD (HD or T-NHL) had signs of HCV contact (i.e., 1.9%, which is in the range of the normal population in the South of Italy), 59 of 263 patients with a B-LPD (22.4%) had HCV antibodies or RNA, or both, with no major differences among the various types of disorders, except for WM, in which the rate was higher (61.5%). The same prevalence was found for patients tested at diagnosis or during the follow-up, and in transfused or never-transfused patients. Only a few patients were aware of having a liver disease; one-half of HCV-positive patients never had transaminase increase. A review of data from Central and Northern Italy is included, showing similar findings; a report from Japan has confirmed such an association, while limited surveys in England have not revealed any correlation. These findings may have important biological and clinical implications.


Subject(s)
Hepatitis C/complications , Lymphoproliferative Disorders/complications , Adolescent , Adult , Age Factors , Aged , B-Lymphocytes , Female , Hepacivirus/classification , Hepatitis B/complications , Hepatitis C/microbiology , Humans , Italy , Lymphoma, Non-Hodgkin/complications , Lymphoproliferative Disorders/microbiology , Male , Middle Aged , RNA, Viral/analysis
2.
J Clin Microbiol ; 33(3): 641-7, 1995 Mar.
Article in English | MEDLINE | ID: mdl-7751370

ABSTRACT

We used a colorimetric polymerase chain reaction (PCR)-based assay in kit form to detect directly human immunodeficiency virus type 1 (HIV-1) proviral gag sequences in peripheral blood cells from 68 healthy blood donors, 51 subjects at risk for HIV infection, 122 patients with HIV-1 infection, 11 patients with indeterminate Western blot (immunoblot) results, 4 blood donors HIV-1 positive by enzyme immunoassay, and 13 children born to HIV-1-seropositive mothers. The results obtained in the blood donors and HIV-1-infected patients demonstrated the high degree of diagnostic specificity and sensitivity of the PCR method. HIV-1 infection was excluded in 10 of the 11 patients with indeterminate Western blot results and in all four enzyme immunoassay-positive blood donors. A diagnosis of HIV infection was ruled out by negative PCR results in 5 of 13 children from seropositive mothers, which excluded vertical transmission of the infection in these cases; these children were younger than 3 months and had positive serological results. Two at-risk patients with negative serological results had positive PCR results. All results were confirmed by conventional PCR. In conclusion, colorimetric PCR, which is commercially available in kit form, is an easy and reliable technique that can be used to detect proviral HIV-1 genomes in blood cells, and despite the limitations owing to HIV genome variability, it is useful in the clinical setting for the diagnosis of HIV infection in selected categories of patients.


Subject(s)
DNA, Viral/blood , HIV-1/isolation & purification , Lymphocytes/virology , Polymerase Chain Reaction/methods , Proviruses/isolation & purification , Blotting, Western , Case-Control Studies , Child , Child, Preschool , HIV Infections/virology , HIV Seropositivity/diagnosis , HIV-1/genetics , HIV-1/immunology , Humans , Infant , Infant, Newborn , Population , Proviruses/genetics , Reproducibility of Results , Sensitivity and Specificity
3.
G Batteriol Virol Immunol ; 81(1-12): 25-31, 1988.
Article in English | MEDLINE | ID: mdl-2856294

ABSTRACT

The Authors have evaluated, by DNA-probe hybridization, the presence of CMV in the cellular fractions of different body fluids from immunocompromised patients. This specific methodology appear to be rapid to perform, adaptable to different clinical samples and sensitive. Even in absence of a supporting evaluation of specific antibodies, direct detection of virus, by DNA-probe, seems to be the most efficient and rapid approach to confirm the diagnosis either of active phase or reactivating of CMV infection.


Subject(s)
Antibodies, Viral/analysis , Cytomegalovirus Infections/diagnosis , Cytomegalovirus/isolation & purification , Immune Tolerance , Immunoglobulin M/analysis , Adolescent , Adult , Child , Child, Preschool , Cytomegalovirus/immunology , DNA Probes , Humans , Infant , Infant, Newborn , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...